萬潤股份(002643.SZ):光刻膠單體、光刻膠樹脂、光致產酸劑以及半導體制程中清洗劑添加材料等,並已有相關產品實現供應
格隆匯1月15日丨萬潤股份(002643.SZ)在投資者互動平台表示,公司目前在半導體制造材料領域的相關產品主要包括光刻膠單體、光刻膠樹脂、光致產酸劑以及半導體制程中清洗劑添加材料等,並已有相關產品實現供應。公司半導體用光刻膠單體和光刻膠樹脂產品種類及生產技術覆蓋大部分主要產品。在產品開發方面,公司也在積極開發其他品類的半導體制造材料,希望能夠早日完成開發並實現供應。目前公司在所涉足的半導體材料領域已經具有國內領先的技術水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.